Modeling effects of SGLT‐2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes
J Dziuba, P Alperin, J Racketa, U Iloeje… - Diabetes, Obesity …, 2014 - Wiley Online Library
Aims Dapagliflozin, a sodium‐glucose cotransporter 2 (SGLT‐2) inhibitor, has been shown
to lower glycated hemoglobin (HbA1c), weight, blood pressure and serum uric acid in …
to lower glycated hemoglobin (HbA1c), weight, blood pressure and serum uric acid in …
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis
JA Gaebler, G Soto-Campos, P Alperin… - Vascular Health and …, 2012 - Taylor & Francis
Background Patients with type 2 diabetes (T2DM) are at risk of long-term vascular
complications. In trials, exenatide once weekly (ExQW), a GLP-1R agonist, improved …
complications. In trials, exenatide once weekly (ExQW), a GLP-1R agonist, improved …
Cardiovascular outcomes associated with a new once‐weekly GLP‐1 receptor agonist vs. traditional therapies for type 2 diabetes: a simulation analysis
BR Peskin, AV Shcheprov, KS Boye… - Diabetes, Obesity …, 2011 - Wiley Online Library
Aim: The effect of glucose‐lowering agents on diabetes‐related complications including
cardiovascular (CV) events is of major importance. In the absence of a long‐term study, we …
cardiovascular (CV) events is of major importance. In the absence of a long‐term study, we …
Computational principles for an autonomous active vision system
L Sherbakov - 2014 - search.proquest.com
Vision research has uncovered computational principles that generalize across species and
brain area. However, these biological mechanisms are not frequently implemented in …
brain area. However, these biological mechanisms are not frequently implemented in …